Related Experiment Videos

Cyclin D1, another molecule of the year?

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|March 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

ESMO open·2023

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

ESMO open·2022

Resilience and unmet supportive care needs in patients with cancer during early treatment: A descriptive study.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2015

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06).

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).

Lung cancer (Amsterdam, Netherlands)·2014

[The role of EGFR in non-small cell lung carcinoma].

Revue medicale suisse·2009

See all related articles